Username:
Password:
Remember Me.


Our team of journalists reports each day (Mon-Fri) on the latest opinions, recommendations, targets and forecasts by the ten leading stock brokers and equity investment advisers in the Australian market.

The Australian Broker Call is made available to its subscribers each morning before the opening of the Australian share market at 10am.



Our tagline 'Offers Unprecedented Insights Into The Australian Share Market' already gives it away. This report combines all the information available in the FN Arena database and makes it accessible in an easy to use monthly pdf report.

Subscribers to the Australian Broker Call Report now have access to five additional services which, together, add tremendous value to our daily news report. (For an overview of all services, please see the signup page on this website).

We strongly believe the combination of all our products offers our subscribers with better insight into what's happening in the Australian share market by revealing the underlying views and sentiments that drive share price valuations either northward, or southward.



Australian Banks: Stuck In The Middle With You
As three of Australia's four big banks prepare to deliver earnings reports next week, brokers contemplate whether share prices have any reason to go either up or down.
Surfstitch Sews Upside Potential
Surfstitch has upgraded estimates for FY15, with substantial synergies emanating from the consolidation of European operations.
Opportunity In Ramsay
Michael Gable of Fairmont Equities suggests a pullback for Ramsay Healthcare is not an opportunity to be missed.
Your Editor On Switzer: Hidden Barriers
Sometimes an unquantified risk is holding back the share price, explains FNArena Editor Rudi Filapek-Vandyck
Uranium Week: Slipping Away
Sellers are being forced to lower prices in the face of a lack of spot market buying interest from utilities.
The Overnight Report: Iron Willed
The iron ore rebound has given global materials stocks a new lease of life although a sell-off in biotech spoiled the party for Wall Street last night. Dow down 42. (Accessible only for subscribers before 10:15 AEST)
Today's Financial Calendar
Significant Scheduled Events For 28 April, 2015
Is ResMed Sell-Off Overdone?
ResMed revealed strong growth in flow generator sales in the US in the March quarter but disappointed the market when it came to masks.
Eureka Stakes Out Position In Seniors' Living
Eureka Group intends to become a significant owner operator of independent retirement units and Canaccord Genuity initiates coverage on the stock.
ASX200 Set To Break?
Nick Linton-Ffrost of Fifth Wave suggests the ASX200 is building for a break-out of its trading range, favouring the upside.
Aust Pharma Beset By PBS Uncertainty
Australian Pharmaceutical Industries impressed brokers with its retail expansion but uncertainties prevail in its wholesale division.
Weekly Recommendation, Target Price, Earnings Forecast Changes
Weekly update on recommendation, target price, and earnings forecast changes.

There's more news inside. Simply sign up for a free trial (no obligation) and receive daily and weekly emails. You can always unsubscribe later.

The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface. This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
© News Network 2015. All Rights Reserved. No portion of this website may be reproduced, copied or in any way re-used without written permission from News Network. All subscribers should read our terms and conditions.